Overall, the strategy of excluding MHC improved the resolution of the genetic overlap between IBD and RA, ensuring that the results mainly reflect non-HLA genetic commonality rather than just the effect of a single MHC hotspot. The gene discussed is HLA-C; the disease is inflammatory bowel disease.